Scienture Holdings, Inc. (SCNX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$491.8K

Year ended 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$491.8K	n/a	2026-03-30, From 2025-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Scienture Holdings, Inc. (SCNX)	2025-12-31	$491.8K	n/a
Medicinova Inc (MNOV)	2025-12-31	$20.1K	-4.6%
Can-Fite BioPharma Ltd. (CANF)	2025-12-31	$24.0K	+242.9%
Lipella Pharmaceuticals Inc. (LIPO)	2024-12-31	$2.9K	+71.3%
Quantum Cyber N.V. (QUCY)	2025-12-31	$615.7K	-11.6%
Yarrow Bioscience, Inc. (YARW)	2025-12-31	$23.0K	+475.0%
Allarity Therapeutics, Inc. (ALLR)	2024-12-31	$9.0K	-75.7%
Vyome Holdings, Inc (HIND)	2025-12-31	$12.0K	-30.9%
PMGC Holdings Inc. (ELAB)	2025-12-31	$96.1K	n/m

Compare SCNX, MNOV, CANF, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗